Search academic texts

Information × Registration Number 0219U003372, 0116U000273 , R & D reports Title To develop a technology for the manufacture of polyvalent culture vaccine against Marek's disease. popup.stage_title Head Stegniy Marina, Доктор ветеринарних наук Registration Date 06-02-2019 Organization Nationali Scientific Center "Institute of Experimental and Clinical Veterinary Medicine" popup.description2 3. The object of the study is the safety and immunogenicity of experimental samples of culture polyvalent vaccine against Marek's disease. The purpose of the work is to develop a technology for the manufacture of a cultural polyvalent vaccine against Marek's disease. Research methods - virological, morphological, immunological, biotechnological, biological. The data are presented, according to the results of the experiments on chickens, the harmlessness of the experimental sample of the polyvalent culture vaccine against HM in a tenfold shaving dose and immunogenicity of 98-100% in experimental conditions and 98.5% in clinical trials were established. A patent was received for a utility model of Ukraine No. 116658 "An atenuated strain of the Marek's disease virus of the first serotype 4/11, as an integral component of the Marek's multivalent culture vaccine against Marek's disease" ; polyvalent culture vaccine against Marek's disease from strains (SBG, FC-126, 4/11). The vaccine is polyvalent, cultural against HM, which increases the protection of the animal head in the dysfunctional HM farms. Product Description popup.authors Богач Микола Володимирович Грицина Наталя Валеріївна Магац Дар'я Юріївна Стегній Борис Тимофійович Стегній Марина Юріївна popup.nrat_date 2020-04-02 Close